Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Mizutani
Observed name:
A Mizutani
Institution:
Japanese Foundation For Cancer Research
Observed institutions:
Japanese Foundation For Cancer Research,
The University of Tokyo
OpenAlex ID:
A5113798397
Works
26
Awards
3
ZEB 1‐regulated inflammatory phenotype in breast cancer cells
2017
·
Akihiro Katsura
, Yusuke Tamura
, et al.
·
Molecular Oncology
·
124
PDF
APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
2017
·
Noritaka Tanaka
, Tetsuo Mashima
, et al.
·
Molecular Cancer Therapeutics
·
93
BMP Sustains Embryonic Stem Cell Self-Renewal through Distinct Functions of Different Krüppel-like Factors
2016
·
Masato Morikawa
, Daizo Koinuma
, et al.
·
Stem Cell Reports
·
90
PDF
RK ‐287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model
2018
·
Anna Mizutani
, Yoko Yashiroda
, et al.
·
Cancer Science
·
89
PDF
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors
2019
·
Fumiyuki Shirai
, Takeshi Tsumura
, et al.
·
Journal of Medicinal Chemistry
·
58
Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4α in HepG2 Cells
2011
·
Anna Mizutani
, Daizo Koinuma
, et al.
·
Journal of Biological Chemistry
·
53
PDF
The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma
2015
·
A Mizutani
, D Koinuma
, et al.
·
Oncogene
·
48
PDF
Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program
2016
·
Eleftheria Vasilaki
, Masato Morikawa
, et al.
·
Science Signaling
·
45
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer
2020
·
Fumiyuki Shirai
, Anna Mizutani
, et al.
·
Journal of Medicinal Chemistry
·
40
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development
2018
·
Yo-Taro Shirai
, Anna Mizutani
, et al.
·
Oncogene
·
33
PDF
mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer
2017
·
Tetsuo Mashima
, Yoko Taneda
, et al.
·
Oncotarget
·
32
PDF
Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells
2017
·
Mayu Arase
, Yusuke Tamura
, et al.
·
Scientific Reports
·
31
PDF
Arkadia complexes with clathrin adaptor AP2 and regulates EGF signalling
2010
·
Anna Mizutani
, Masao Saitoh
, et al.
·
The Journal of Biochemistry
·
18
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells
2023
·
Mingjue Chen
, Tetsuo Mashima
, et al.
·
British Journal of Cancer
·
16
PDF
Adaptor protein complex of FRS 2β and CIN 85/ CD 2 AP provides a novel mechanism for ErbB2/ HER 2 protein downregulation
2013
·
Yuriko Minegishi
, Yoshio Shibagaki
, et al.
·
Cancer Science
·
13
PDF
Tankyrase promotes primary precursor miRNA processing to precursor miRNA
2019
·
Anna Mizutani
, Hiroyuki Seimiya
·
Biochemical and Biophysical Research Communications
·
6
Abstract 2131: The Arkadia-ESRP2 axis suppresses tumor progression: Analyses in clear cell renal cell carcinoma
2015
·
Anna Mizutani
, Daizo Koinuma
, et al.
·
Cancer Research
·
1
Supplementary Figure S1-S8 from APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
2023
·
Noritaka Tanaka
, Tetsuo Mashima
, et al.
Supplementary Figure Legends from APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
2023
·
Noritaka Tanaka
, Tetsuo Mashima
, et al.
Supplementary Table S1 from APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
2023
·
Noritaka Tanaka
, Tetsuo Mashima
, et al.
Supplementary Table S2 from APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
2023
·
Noritaka Tanaka
, Tetsuo Mashima
, et al.
Data from APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
2023
·
Noritaka Tanaka
, Tetsuo Mashima
, et al.
Data from APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
2023
·
Noritaka Tanaka
, Tetsuo Mashima
, et al.
Design and Discoveryof an Orally Efficacious Spiroindolinone-BasedTankyrase Inhibitor for the Treatment of Colon Cancer
2020
·
Fumiyuki Shirai
, Anna Mizutani
, et al.
·
Figshare
ZEB1 associated secretory phenotype in breast cancer cells
2016
·
Yusuke Tamura
, Akihiro Katsura
, et al.
·
The Molecular Biology Society of Japan
Show more works
View as search
Works count:
26
Citation count:
790
H-index:
14
I10-index:
15
Year
Topic
Type